Skip to main content

FDA recall, , Moderate risk

Philips Azurion Systems

Philips Azurion Systems have software issues that may cause system restarts and positional errors.

What happened

PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. is recalling Philips Azurion Systems with software versions R2.1.10 and R2.2.10.

The recall is due to six identified software issues that may result in the system keeping restarting, the AMC triple drive, the C-Partition of the Suite PC running out of free space, the system remaining in continuous restart mode after start-up, misalignment of the Market Tool Overlay, and a longitudinal positional error.

The recall was initiated on December 12, 2025, and was added to the FDA's Enforcement Report on January 14, 2026.

The affected products include Azurion 3 M12, Azurion 3 M15, Azurion 5 M12, Azurion 5 M20, Azurion 7 B12, Azurion 7 B20, and Azurion 7 M12 systems. The distribution is worldwide, including the US nationwide and many other countries.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medical device recalls:

  1. A device recall doesn't always mean you must stop using it: it may need to be checked, adjusted or fixed.
  2. Talk to your health care provider before you stop using it.

Is yours affected?

Compare the details below with your product and check the FDA notice to confirm whether it is affected.

A UDI-DI is the device identifier printed with the barcode on the device label.

  1. Product details

    Philips Azurion Systems with software versions R2.1.10 and R2.2.10. Includes the following label descriptions and corresponding models: 1. Azurion 3 M12. Model Numbers: 722063, 722221. 2. Azurion 3 M15. Model Numbers: 722064, 722222, 722280. 3. Azurion 5 M12.

    Model
    • 722227
    UDI-DI
    • 00884838085275
    • 00884838099203
    • 00884838085282
    • 00884838099210
    • 00884838103276
    • 00884838099227
    • 4838099227
    • 00884838099234
    • 00884838110564
    • 00884838085350
    • 00884838099265
    • 00884838085367
    • 00884838099272
    • 00884838
    • 00884838085251
    • 00884838099241
    • 00884838085268
    • 008848380
    • 00884838099258
    • 0884838099258
    • 00884838110571

Recall details

Company began the recall
Sold in

Worldwide distribution - US Nationwide and the countries of Afghanistan, Albania, Algeria, Argentina, Armenia, Australia, Austria, Azerbaijan, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia and Herzegovina, Botswana, Brazil, Brunei Darussalam, Bulgaria, Cambodia, Canada, Cayman Islands, Chile, China, Colombia, Costa Rica, C¿te D'Ivoire, Croatia, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Ethiopia, Fiji, Finland, France, French Polynesia, Germany, Ghana, Gibraltar, Greece, Guadeloupe, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kazakhstan, Kenya, Korea, Republic of, Korea, South, Kosovo, Kuwait, Kyrgyzstan, Lao People's Democratic Republic, Latvia, Lebanon, Libya, Lithuania, Macao, Macedonia, Malaysia, Maldives, Malta, Martinique, Mauritania, Mauritius, Mexico, Moldova, Mongolia, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Nicaragua, Nigeria, Norway, Oman, Pakistan, Palestine, State of, Panama, Peru, Philippines, Poland, Portugal, Qatar, R¿union, Romania, Russian Fed., Russian Federation, Saudi Arabia, Senegal, Serbia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syrian Arab Republic, Taiwan, Tanzania, Thailand, Tunisia, Turkey, Turkmenistan, Ukraine/United Arab Emirate, United Kingdom, Uruguay, Uzbekistan, Viet Nam, Vietnam, Yemen.

Company
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Best, Netherlands
Risk

Moderate risk

Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98096
Recall number
Z-1091-2026
Quantity recalled
10,466 units

All recalls from PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)